Literature DB >> 12656641

The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent.

John B Vincent1.   

Abstract

The element chromium apparently has a role in maintaining proper carbohydrate and lipid metabolism in mammals. As this role probably involves potentiation of insulin signalling, chromium dietary supplementation has been postulated to potentially have effects on body composition, including reducing fat mass and increasing lean body mass. Because the supplement is absorbed better than dietary chromium, most studies have focused on the use of chromium picolinate [Cr(pic)(3)]. Cr(pic)(3) has been amazingly popular with the general public, especially with athletes who may have exercise-induced increased urinary chromium loss; however, its effectiveness in manifesting body composition changes has been an area of intense debate in the last decade. Additionally, claims have appeared that the supplement might give rise to deleterious effects. However, over a decade of human studies with Cr(pic)(3) indicate that the supplement has not demonstrated effects on the body composition of healthy individuals, even when taken in combination with an exercise training programme. Recent cell culture and in vivo rat studies have indicated that Cr(pic)(3) probably generates oxidative damage of DNA and lipids and is mutagenic, although the significance of these results on humans taking the supplement for prolonged periods of time is unknown and should be a focus for future investigations. Given that in vitro studies suggest that other forms of chromium used as nutritional supplements, such as chromium chloride, are unlikely to be susceptible to generating this type of oxidative damage, the use of these compounds, rather than Cr(pic)(3), would appear warranted. Potential neurological effects (both beneficial and deleterious) from Cr(pic)(3) supplementation require further study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12656641     DOI: 10.2165/00007256-200333030-00004

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  78 in total

Review 1.  The role of chromium in nutrition and therapeutics and as a potential toxin.

Authors:  K N Jeejeebhoy
Journal:  Nutr Rev       Date:  1999-11       Impact factor: 7.110

2.  Formation of a substituted 1,N(6)-etheno-2'-deoxyadenosine adduct by lipid hydroperoxide-mediated generation of 4-oxo-2-nonenal.

Authors:  D Rindgen; S H Lee; M Nakajima; I A Blair
Journal:  Chem Res Toxicol       Date:  2000-09       Impact factor: 3.739

3.  Chromium(III) tris(picolinate) is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells.

Authors:  Diane M Stearns; Stacey M Silveira; Kristina K Wolf; April M Luke
Journal:  Mutat Res       Date:  2002-01-15       Impact factor: 2.433

4.  Chromium picolinate toxicity.

Authors:  J Cerulli; D W Grabe; I Gauthier; M Malone; M D McGoldrick
Journal:  Ann Pharmacother       Date:  1998-04       Impact factor: 3.154

5.  [Effect of chromium yeast and chromium picolinate on body composition of obese, non-diabetic patients during and after a formula diet].

Authors:  B Bahadori; S Wallner; H Schneider; T C Wascher; H Toplak
Journal:  Acta Med Austriaca       Date:  1997

6.  Effects of chromium picolinate on body composition.

Authors:  L K Trent; D Thieding-Cancel
Journal:  J Sports Med Phys Fitness       Date:  1995-12       Impact factor: 1.637

7.  Release of Cr(III) from Cr(III) picolinate upon metabolic activation.

Authors:  S A Kareus; C Kelley; H S Walton; P R Sinclair
Journal:  J Hazard Mater       Date:  2001-06-29       Impact factor: 10.588

Review 8.  Effects of exercise on chromium levels. Is supplementation required?

Authors:  P M Clarkson
Journal:  Sports Med       Date:  1997-06       Impact factor: 11.136

9.  Chromium treatment of depression.

Authors:  Malcolm N. McLeod; Robert N. Golden
Journal:  Int J Neuropsychopharmacol       Date:  2000-12       Impact factor: 5.176

10.  Glucose and insulin responses to dietary chromium supplements: a meta-analysis.

Authors:  Michelle D Althuis; Nicole E Jordan; Elizabeth A Ludington; Janet T Wittes
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

View more
  17 in total

1.  Submandibular gland and caries susceptibility in the obese Zucker rat.

Authors:  Mahmood S Mozaffari; Rafik Abdelsayed; Ibrahim Zakhary; Mohammed El-Salanty; Jun Yao Liu; Hereward Wimborne; Ahmed El-Marakby
Journal:  J Oral Pathol Med       Date:  2010-10-25       Impact factor: 4.253

2.  Short-term skin reactions associated to sleeve gastrectomy in eight patients.

Authors:  Maria M Farias; Constanza Gajardo; Veronica Alvarez; Ada Cuevas; Maria L Perez-Cotapos
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

3.  Long-term exposure to [Cr(3)O(O (2)CCH (2)CH (3)) (6)(H (2)O) (3)] (+) in Wistar rats fed normal or high-fat diets does not alter glucose metabolism.

Authors:  Betty J Herring; Amanda L Logsdon; Jarrett E Lockard; Brittany M Miller; Hanna Kim; Eric A Calderon; John B Vincent; Melissa M Bailey
Journal:  Biol Trace Elem Res       Date:  2012-12-29       Impact factor: 3.738

4.  Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.

Authors:  L E Horsfall; G Garau; B M R Liénard; O Dideberg; C J Schofield; J M Frère; M Galleni
Journal:  Antimicrob Agents Chemother       Date:  2007-02-16       Impact factor: 5.191

5.  Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats.

Authors:  Buffie J Clodfelder; Bryan M Gullick; Henry C Lukaski; Yasmin Neggers; John B Vincent
Journal:  J Biol Inorg Chem       Date:  2004-12-30       Impact factor: 3.358

Review 6.  Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? Part B: minerals.

Authors:  Orit Kaidar-Person; Benjamin Person; Samuel Szomstein; Raul J Rosenthal
Journal:  Obes Surg       Date:  2008-05-07       Impact factor: 4.129

Review 7.  Overfed but undernourished: recognizing nutritional inadequacies/deficiencies in patients with overweight or obesity.

Authors:  Arne Astrup; Susanne Bügel
Journal:  Int J Obes (Lond)       Date:  2018-07-06       Impact factor: 5.095

8.  A Dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women.

Authors:  Leonardo Celleno; Maria Vittoria Tolaini; Alessandra D'Amore; Nicholas V Perricone; Harry G Preuss
Journal:  Int J Med Sci       Date:  2007-01-24       Impact factor: 3.738

9.  Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat.

Authors:  Mahmood S Mozaffari; Rafik Abdelsayed; Jun Yao Liu; Hereward Wimborne; Azza El-Remessy; Ahmed El-Marakby
Journal:  Nutr Metab (Lond)       Date:  2009-12-10       Impact factor: 4.169

10.  Opinion controversy to chromium picolinate therapy's safety and efficacy: ignoring 'anecdotes' of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan
Journal:  EPMA J       Date:  2012-10-07       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.